Rishabh Dev

527 total citations
39 papers, 380 citations indexed

About

Rishabh Dev is a scholar working on Immunology, Epidemiology and Pharmacology. According to data from OpenAlex, Rishabh Dev has authored 39 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Epidemiology and 7 papers in Pharmacology. Recurrent topics in Rishabh Dev's work include Pharmacological Effects of Natural Compounds (4 papers), Aortic aneurysm repair treatments (3 papers) and Natural Antidiabetic Agents Studies (3 papers). Rishabh Dev is often cited by papers focused on Pharmacological Effects of Natural Compounds (4 papers), Aortic aneurysm repair treatments (3 papers) and Natural Antidiabetic Agents Studies (3 papers). Rishabh Dev collaborates with scholars based in India, United States and Nepal. Rishabh Dev's co-authors include Nirav Dhanesha, Prakash Doddapattar, Manish Jain, Anil K. Chauhan, Chetan P. Hans, Neekun Sharma, Abhijit Ray, Punit Srivastava, Sunanda G. Dastidar and Madankumar Ghatge and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Rishabh Dev

33 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rishabh Dev India 12 101 94 68 53 41 39 380
Xiu Yu China 12 90 0.9× 178 1.9× 69 1.0× 24 0.5× 40 1.0× 19 447
Weiwei Liu China 11 79 0.8× 185 2.0× 82 1.2× 30 0.6× 45 1.1× 24 476
Wanwan Jia China 12 109 1.1× 255 2.7× 28 0.4× 36 0.7× 53 1.3× 16 490
Junjie Yang China 14 116 1.1× 188 2.0× 32 0.5× 32 0.6× 59 1.4× 42 564
Yong-Min Choi South Korea 7 75 0.7× 228 2.4× 38 0.6× 30 0.6× 80 2.0× 11 479
Caixia Li China 13 112 1.1× 162 1.7× 36 0.5× 81 1.5× 36 0.9× 21 363
Daniel LaSala United States 11 38 0.4× 202 2.1× 75 1.1× 58 1.1× 35 0.9× 17 454

Countries citing papers authored by Rishabh Dev

Since Specialization
Citations

This map shows the geographic impact of Rishabh Dev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rishabh Dev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rishabh Dev more than expected).

Fields of papers citing papers by Rishabh Dev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rishabh Dev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rishabh Dev. The network helps show where Rishabh Dev may publish in the future.

Co-authorship network of co-authors of Rishabh Dev

This figure shows the co-authorship network connecting the top 25 collaborators of Rishabh Dev. A scholar is included among the top collaborators of Rishabh Dev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rishabh Dev. Rishabh Dev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Balkrishna, Acharya, et al.. (2025). Polystyrene microplastic induced airway hyper-responsiveness, and pulmonary inflammation are mitigated by bronchom treatment in murine model of lung disease. Biomedicine & Pharmacotherapy. 187. 118122–118122. 1 indexed citations
5.
Balkrishna, Acharya, Rishabh Dev, Sandeep Kumar, & Anurag Varshney. (2024). Coronil effectively inhibits the interaction of clinically relevant Omicron mutants of SARS-CoV-2 spike proteins with human ACE2 receptor. Phytomedicine Plus. 5(1). 100705–100705. 1 indexed citations
9.
Balkrishna, Acharya, et al.. (2024). Fevogrit, a polyherbal medicine, mitigates endotoxin (lipopolysaccharide)‐induced fever in Wistar rats by regulating pro‐inflammatory cytokine levels. SHILAP Revista de lepidopterología. 8(4). 728–738. 1 indexed citations
11.
Balkrishna, Acharya, et al.. (2023). Melanogrit potentiates melanogenesis by escalating cellular tyrosinase activity and MITF levels via pERK inhibition. Bioscience Reports. 44(1). 3 indexed citations
12.
Balkrishna, Acharya, et al.. (2023). Anti-oxidant response of lipidom modulates lipid metabolism in Caenorhabditis elegans and in OxLDL-induced human macrophages by tuning inflammatory mediators. Biomedicine & Pharmacotherapy. 160. 114309–114309. 12 indexed citations
15.
Balkrishna, Acharya, Sudeep Goswami, Hoshiyar Singh, et al.. (2022). Herbo-mineral formulation, Divya-Swasari-Vati averts SARS-CoV-2 pseudovirus entry into human alveolar epithelial cells by interfering with spike protein-ACE 2 interaction and IL-6/TNF-α /NF-κB signaling. Frontiers in Pharmacology. 13. 1024830–1024830. 4 indexed citations
16.
Balkrishna, Acharya, Kunal Bhattacharya, Sandeep Sinha, et al.. (2022). Apparent Hepatotoxicity of Giloy (Tinospora cordifolia): Far From What Meets the Eyes. Journal of Clinical and Experimental Hepatology. 12(1). 239–240. 3 indexed citations
17.
Hans, Chetan P., Neekun Sharma, Sidharth Sen, et al.. (2019). Transcriptomics Analysis Reveals New Insights into the Roles of Notch1 Signaling on Macrophage Polarization. Scientific Reports. 9(1). 7999–7999. 23 indexed citations
18.
Sharma, Neekun, Rishabh Dev, Juan de Dios Ruiz‐Rosado, et al.. (2019). Pharmacological inhibition of Notch signaling regresses pre-established abdominal aortic aneurysm. Scientific Reports. 9(1). 13458–13458. 26 indexed citations
19.
Dev, Rishabh, et al.. (2010). Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain. Expert Opinion on Investigational Drugs. 19(4). 455–468. 21 indexed citations
20.
Srivastava, Punit, et al.. (2009). Prostaglandin E2synthase inhibition as a therapeutic target. Expert Opinion on Therapeutic Targets. 13(7). 849–865. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026